Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D study (Q28269390)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D study	scientific article

Statements

scholarly article

0 references

Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D study (English)

0 references

6

0 references

4

0 references

Jordan W Smoller

8

object named as

Jordan W Smoller

0 references

Augustus John Rush

7

object named as

A John Rush

0 references

Madhukar Trivedi

5

object named as

Madhukar H Trivedi

0 references

1

object named as

Roy H Perlis

0 references

Jesen Fagerness

3

object named as

Jesen Fagerness

0 references

author name string

Priya Moorjani

2

0 references

language of work or name

0 references

publication date

November 2008

0 references

Neuropsychopharmacology

0 references

33

0 references

12

0 references

2810-9

0 references

Efficiency and power in genetic association studies

1 reference

https://api.crossref.org/works/10.1038/NPP.2008.6

21 April 2017

The neuronal background K2P channels: focus on TREK1

1 reference

https://api.crossref.org/works/10.1038/NPP.2008.6

21 April 2017

Inhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetine

1 reference

https://api.crossref.org/works/10.1038/NPP.2008.6

21 April 2017

Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment

1 reference

https://api.crossref.org/works/10.1038/NPP.2008.6

21 April 2017

Sequential phosphorylation mediates receptor- and kinase-induced inhibition of TREK-1 background potassium channels

1 reference

https://api.crossref.org/works/10.1038/NPP.2008.6

21 April 2017

PLINK: a tool set for whole-genome association and population-based linkage analyses

1 reference

https://api.crossref.org/works/10.1038/NPP.2008.6

21 April 2017

Alterations in 5-HT1B receptor function by p11 in depression-like states

1 reference

https://api.crossref.org/works/10.1038/NPP.2008.6

21 April 2017

Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 April 2017

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 April 2017

Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 April 2017

High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Pharmacogenomic evaluation of the antidepressant citalopram in the mouse tail suspension test.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Diagnosis and definition of treatment-resistant depression

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Definition and epidemiology of treatment-resistant depression

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Strengthening clinical effectiveness trials: equipoise-stratified randomization.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

PIP2 hydrolysis underlies agonist-induced inhibition and regulates voltage gating of two-pore domain K+ channels.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Pharmacogenetics of psychotropic drug response

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Pharmacogenetics of antidepressant medication intolerance

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

The future of association studies: gene-based analysis and replication

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Set association analysis of SNP case-control and microarray data

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

How do antidepressants work? Prospects for genetic analysis of drug mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Pooling pharmacogenetic studies on the serotonin transporter: a mega-analysis.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Spurious genetic associations

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Outcome definitions and predictors in depression

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Medication augmentation after the failure of SSRIs for depression.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Placebo response in studies of major depression: variable, substantial, and growing

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

21 January 2018

Cloning, functional expression and brain localization of a novel unconventional outward rectifier K+ channel

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

7 January 2021

based on heuristic

inferred from DOI database lookup

TREKing toward new antidepressants

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

7 January 2021

based on heuristic

inferred from DOI database lookup

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

7 January 2021

based on heuristic

inferred from DOI database lookup

Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

7 January 2021

based on heuristic

inferred from DOI database lookup

The Inventory of Depressive Symptomatology (IDS): psychometric properties.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cns distribution of members of the two-pore-domain (KCNK) potassium channel family.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28269390&oldid=2175170592"